1.
Covidization of research: what are the risks?
by Pai, Madhukar
Nature medicine, 2020-08, Vol.26 (8), p.1159-1159
2.
Author Correction: Covidization of research: what are the risks?
by Pai, Madhukar
Nature medicine, 2020-11-01, Vol.26 (11), p.1801-1801
3.
Use of standardised patients to assess quality of tuberculosis care: a pilot, cross-sectional study
by Das, Jishnu, PhD
The Lancet infectious diseases, 2015, Vol.15 (11), p.1305-1313
4.
COVID-19 boosters in rich nations will delay vaccines for all
by Chagla, Zain
Nature medicine, 2021-10-01, Vol.27 (10), p.1659-1660
5.
Use of standardised patients to assess antibiotic dispensing for tuberculosis by pharmacies in urban India: a cross-sectional study
by Satyanarayana, Srinath, MD
The Lancet infectious diseases, 2016, Vol.16 (11), p.1261-1268
6.
Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis
by Rangaka, Molebogeng X, MBChB
The Lancet infectious diseases, 2012, Vol.12 (1), p.45-55
7.
As India grows, tuberculosis control must not be left behind
by Pai, Madhukar
The Lancet infectious diseases, 2012, Vol.12 (4), p.263-265
8.
Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analy...
by Morrison, Janina, MD
The Lancet infectious diseases, 2008, Vol.8 (6), p.359-368
9.
Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial
by Theron, Grant, PhD
The Lancet (British edition), 2014, Vol.383 (9915), p.424-435
10.
Diagnostics for tuberculosis: what test developers want to know
by Pai, Madhukar
Expert review of molecular diagnostics, 2013-05-01, Vol.13 (4), p.311-314
11.
Promoting diagnostics as a global good
by Boehme, Catharina
Nature medicine, 2021-03, Vol.27 (3), p.367-368
12.
Interferon-gamma release assays for tuberculosis screening of healthcare workers: a systematic review
by Zwerling, Alice
Thorax, 2012-01, Vol.67 (1), p.62-70
13.
Tuberculosis 4: Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
by Robert S Wallis
The Lancet (British edition), 2010-05-29, Vol.375 (9729), p.1920
14.
Tuberculosis in India: health policy alone is not enough – Authors' reply
by Pai, Madhukar
The Lancet (British edition), 2017-06-24, Vol.389 (10088), p.2471-2472
15.
Improving TB diagnosis: difference between knowing the path and walking the path
by Pai, Madhukar
Expert review of molecular diagnostics, 2011-04-01, Vol.11 (3), p.241-244
16.
Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis
by Minion, Jessica, MD
The Lancet infectious diseases, 2010, Vol.10 (10), p.688-698
17.
Reducing global tuberculosis deaths—time for India to step up
by Pai, Madhukar
The Lancet (British edition), 2017, Vol.389 (10075), p.1174-1176
18.
Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review
by Pai, Madhukar
The Lancet infectious diseases, 2004-12, Vol.4 (12), p.761-776
19.
Recent advances in the diagnosis of childhood tuberculosis
by Marais, Ben J
Archives of disease in childhood, 2007-05, Vol.92 (5), p.446-452
20.
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice
by Wallis, Robert S, MD
The Lancet (British edition), 2010, Vol.375 (9729), p.1920-1937
